Harbour Investments’s Astrana Health ASTH Stock Holding History

Harbour Investments’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-138	Closed	-$13K	–	3759
2021 Q3	$13K	Buy	+138	New	+$11.7K	﹤0.01%	2540

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Harbour Investments's ASTH Position: Q4 2021 in Review

Harbour Investments sold out of Astrana Health (ASTH) in Q4 2021, closing a stake of 138 shares — an estimated $13K sold.

Harbour Investments first reported a position in ASTH in Q3 2021 and held it in 1 quarter. The position peaked at $13K in Q3 2021. 149 funds tracked by Wall St. Rank hold ASTH as of Q4 2021.

Harbour Investments reported no remaining Astrana Health position as of Q4 2021 after selling out during the quarter.
Harbour Investments sold 138 Astrana Health shares in Q4 2021, an estimated $13K.
Harbour Investments first reported a position in Astrana Health in Q3 2021 and held it in 1 quarter.
Harbour Investments's Astrana Health position peaked at $13K in Q3 2021.
149 funds tracked by Wall St. Rank held Astrana Health as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.